How a new "breathalyzer" from the College of Veterinary Medicine could change the future of canine heart health.
Heart disease affects approximately 10 percent of dogs in their lifetime 1 VETMEDIN® (pimobendan) from Boehringer Ingelheim is the only medication approved to treat preclinical mitral valve disease in ...
The MarketWatch News Department was not involved in the creation of this content. -- Heart disease affects approximately 10 percent of dogs in their lifetime1 -- VETMEDIN(R) (pimobendan) from ...
Jan 19 (Reuters) - Pharmaceutical company Boehringer Ingelheim said on Monday the U.S. Food and Drug Administration had approved its chewable tablet, as the first drug to delay congestive heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results